newsfilter
← Latest News
GlobeNewswire·

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment Conference

BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (NASDAQ:RVLP) ("RVL" or the "Company"), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, will present at the H.C. Wainwright 2